Stocks
Healthcare Services Group Financial Statements (HCSG) |
||||||||||
| Healthcare Services Groupsmart-lab.ru | % | 2021 | 2022 | 2022 | 2023 | LTM ? | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 18.02.2022 | 30.06.2022 | 31.12.2022 | 17.02.2023 | 16.02.2024 | 25.10.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 1 642 | 1 642 | 1 690 | 1 690 | 1 671 | 1 709 | |||
| Operating Income, bln rub | 31.0 | 31.0 | 53.5 | 53.5 | 62.4 | 30.2 | ||||
| EBITDA, bln rub | ? | 77.9 | 45.7 | 45.1 | 62.9 | 75.2 | 50.9 | |||
| Net profit, bln rub | ? | 48.5 | 45.9 | 34.6 | 34.2 | 38.4 | 24.5 | |||
| OCF, bln rub | ? | 37.1 | 37.1 | -8.17 | 43.5 | 20.6 | ||||
| CAPEX, bln rub | ? | 5.69 | 5.69 | 5.21 | 5.41 | 2.71 | ||||
| FCF, bln rub | ? | 31.4 | 31.4 | -13.4 | 38.1 | 17.9 | ||||
| Dividend payout, bln rub | 62.2 | 62.2 | 63.4 | 0.000 | 0.000 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 128.2% | 135.7% | 0.00% | 185.1% | 0.00% | 0 | ||||
| OPEX, bln rub | 173.1 | 173.1 | 140.3 | 140.3 | 189.1 | 230.9 | ||||
| Cost of production, bln rub | 1 415 | 1 415 | 1 496 | 1 496 | 1 420 | 1 467 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 1.39 | 1.39 | 0.000 | 2.99 | 7.86 | 3.26 | ||||
| Assets, bln rub | 777.5 | 740.1 | 718.3 | 718.3 | 790.7 | 805.8 | ||||
| Net Assets, bln rub | ? | 452.7 | 437.8 | 426.2 | 426.2 | 456.6 | 488.7 | |||
| Debt, bln rub | 11.3 | 9.86 | 0.000 | 33.1 | 36.2 | 34.0 | ||||
| Cash, bln rub | 185.2 | 129.2 | 121.5 | 121.5 | 147.5 | 103.8 | ||||
| Net debt, bln rub | -173.9 | -119.3 | -121.5 | -88.4 | -111.2 | -69.8 | ||||
| Ordinary share price, rub | 17.8 | 17.4 | 12.0 | 12.0 | 10.4 | 9.86 | ||||
| Number of ordinary shares, mln | 74.8 | 74.8 | 74.3 | 74.3 | 74.3 | 73.7 | ||||
| Market cap, bln rub | 1 331 | 1 303 | 892 | 892 | 770 | 727 | ||||
| EV, bln rub | ? | 1 157 | 1 183 | 771 | 804 | 659 | 657 | |||
| Book value, bln rub | 357 | 344 | 335 | 335 | 369 | 403 | ||||
| EPS, rub | ? | 0.65 | 0.61 | 0.47 | 0.46 | 0.52 | 0.33 | |||
| FCF/share, rub | 0.42 | 0.42 | 0.00 | -0.18 | 0.51 | 0.24 | ||||
| BV/share, rub | 4.77 | 4.60 | 4.50 | 4.50 | 4.97 | 5.47 | ||||
| EBITDA margin, % | ? | 4.74% | 2.78% | 2.67% | 3.72% | 4.50% | 2.98% | |||
| Net margin, % | ? | 2.96% | 2.79% | 2.05% | 2.03% | 2.30% | 1.43% | |||
| FCF yield, % | ? | 2.36% | 2.41% | 0.00% | -1.50% | 4.94% | 2.47% | |||
| ROE, % | ? | 10.7% | 10.5% | 8.13% | 8.04% | 8.41% | 5.01% | |||
| ROA, % | ? | 6.24% | 6.20% | 4.82% | 4.77% | 4.85% | 3.04% | |||
| P/E | ? | 27.4 | 28.4 | 25.8 | 26.1 | 20.1 | 29.7 | |||
| P/FCF | 42.4 | 41.5 | -66.7 | 20.2 | 40.5 | |||||
| P/S | ? | 0.81 | 0.79 | 0.53 | 0.53 | 0.46 | 0.43 | |||
| P/BV | ? | 3.73 | 3.79 | 2.67 | 2.67 | 2.09 | 1.80 | |||
| EV/EBITDA | ? | 14.9 | 25.9 | 17.1 | 12.8 | 8.76 | 12.9 | |||
| Debt/EBITDA | -2.23 | -2.61 | -2.69 | -1.40 | -1.48 | -1.37 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| CAPEX/Revenue, % | 0.35% | 0.35% | 0.00% | 0.31% | 0.32% | 0.16% | ||||
| Healthcare Services Group shareholders | ||||||||||
